[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100478358":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":12,"responsibleParty":30,"collaborators":10,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":37,"acronym":10,"eligibilityCriteria":38,"healthyVolunteers":35,"sex":39,"minAge":40,"maxAge":10,"enrollmentInfo":41,"targetDuration":10,"studyType":44,"phases":10,"briefSummary":45,"conditions":46,"keywords":49,"overallStatus":15,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"University Hospital of Ferrara","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Beta-thalassemia",null,"Patients with Beta-thalassemia undergoing a cardiological evaluation",[13],{"facility":14,"status":15,"city":16,"state":10,"zip":10,"country":17,"countryCode":18,"cosmosGeoPoint":19,"geoPoint":24,"contacts":25},"Matteo Bertini","RECRUITING","Ferrara","Italy","IT",{"type":20,"coordinates":21},"Point",[22,23],11.62057,44.83804,{"lat":23,"lon":22},[26],{"name":14,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","+39 0532236269","brtmtt2@unife.it",{"type":31,"investigatorFullName":14,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Associate Professor","100478358","atrial-fibrillation-in-beta-thalassemia-100478358",false,"NCT05508932","Atrial Fibrillation in Beta-Thalassemia","Inclusion Criteria:\n\n1. Transfusion-dependent Beta-thalassemia;\n2. Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;\n3. Electrocardiogram performed;\n4. Echocardiogram performed.\n\nExclusion Criteria:\n\n1. Age \\\u003C18 years;\n2. State Of pregnancy;\n3. Inability to give informed consent.","ALL","18 Years",{"count":42,"type":43},350,"ESTIMATED","OBSERVATIONAL","The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.",[47,48],"Atrial Fibrillation","Thalassemia",[47,48,50,51,52],"Thalassaemia","Arrhythmia","Hemoglobinopathies","2026-02-21",{"date":55,"type":56},"2026-02-24","ACTUAL",{"date":58,"type":56},"2022-09-01",{"date":60,"type":43},"2032-07-01",{"name":5,"class":6},1]